155 related articles for article (PubMed ID: 19098302)
21. Serum amyloid A concentrations in giant-cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease.
Hachulla E; Saile R; Parra HJ; Hatron PY; Gosset D; Fruchart JC; Devulder B
Clin Exp Rheumatol; 1991; 9(2):157-63. PubMed ID: 1711943
[TBL] [Abstract][Full Text] [Related]
22. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis.
Myklebust G; Gran JT
Br J Rheumatol; 1996 Nov; 35(11):1161-8. PubMed ID: 8948307
[TBL] [Abstract][Full Text] [Related]
23. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
Durkin SR; Athanasiov PA; Crompton JL
Aust Fam Physician; 2006 Nov; 35(11):889-91. PubMed ID: 17099810
[TBL] [Abstract][Full Text] [Related]
24. MMP-3 can distinguish isolated PMR from PMR with GCA: A retrospective study regarding PMR and GCA in Japan.
Fukui S; Nunokawa T; Kobayashi S; Kamei S; Yokogawa N; Takizawa Y; Shimada K; Sugii S; Setoguchi K
Mod Rheumatol; 2016; 26(2):259-64. PubMed ID: 26156043
[TBL] [Abstract][Full Text] [Related]
25. High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumatica.
van Sleen Y; Boots AMH; Abdulahad WH; Bijzet J; Sandovici M; van der Geest KSM; Brouwer E
Rheumatology (Oxford); 2020 Jan; 59(1):176-184. PubMed ID: 31292652
[TBL] [Abstract][Full Text] [Related]
26. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
Salvarani C; Casali B; Boiardi L; Ranzi A; Macchioni P; Nicoli D; Farnetti E; Brini M; Portioli I
J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
[TBL] [Abstract][Full Text] [Related]
27. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
[TBL] [Abstract][Full Text] [Related]
28. [Giant cell arteritis and polymyalgia rheumatica: diagnosis and evolution of 90 cases].
Rivero Puente A; Berasategui Calderón JI; Murie Carrillo De Albornoz JM; Rivero Marcotegui M; García-Bragado Acín F
An Med Interna; 2001 Apr; 18(4):191-4. PubMed ID: 11496538
[TBL] [Abstract][Full Text] [Related]
29. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association.
Dababneh A; Gonzalez-Gay MA; Garcia-Porrua C; Hajeer A; Thomson W; Ollier W
J Rheumatol; 1998 Nov; 25(11):2140-5. PubMed ID: 9818656
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and serological findings of giant-cell arteritis].
Vaith P; Warnatz K
Z Rheumatol; 2009 Mar; 68(2):124-31. PubMed ID: 19159939
[TBL] [Abstract][Full Text] [Related]
31. Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica.
Graver JC; Abdulahad W; van der Geest KSM; Heeringa P; Boots AMH; Brouwer E; Sandovici M
J Autoimmun; 2021 Sep; 123():102684. PubMed ID: 34237649
[TBL] [Abstract][Full Text] [Related]
32. Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.
Lopez-Hoyos M; Bartolome-Pacheco MJ; Blanco R; Rodriguez-Valverde V; Martinez-Taboada VM
Ann Rheum Dis; 2004 Jan; 63(1):54-60. PubMed ID: 14672892
[TBL] [Abstract][Full Text] [Related]
33. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.
Kyle V; Cawston TE; Hazleman BL
Ann Rheum Dis; 1989 Aug; 48(8):667-71. PubMed ID: 2782977
[TBL] [Abstract][Full Text] [Related]
34. Polymyalgia rheumatica and giant cell arteritis: circulating immune complexes.
Espinoza LR; Bridgeford P; Lowenstein M; Bocanegra TS; Vasey FB; Germain BF
J Rheumatol; 1982; 9(4):556-60. PubMed ID: 6215486
[TBL] [Abstract][Full Text] [Related]
35. NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica.
Dejaco C; Duftner C; Al-Massad J; Wagner AD; Park JK; Fessler J; Aigelsreiter A; Hafner F; Vega S; Sterlacci W; Grubeck-Loebenstein B; Tzankov A; Ness T; Boiardi L; Salvarani C; Schirmer M
Ann Rheum Dis; 2013 Nov; 72(11):1852-9. PubMed ID: 23417963
[TBL] [Abstract][Full Text] [Related]
36. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
Ann Rheum Dis; 2005 Dec; 64(12):1765-8. PubMed ID: 15843445
[TBL] [Abstract][Full Text] [Related]
37. Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica.
Reitsema RD; Hesselink BC; Abdulahad WH; van der Geest KSM; Brouwer E; Heeringa P; van Sleen Y
Front Immunol; 2023; 14():1201575. PubMed ID: 37600779
[TBL] [Abstract][Full Text] [Related]
38. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis.
Pountain GD; Calvin J; Hazleman BL
Br J Rheumatol; 1994 Jun; 33(6):550-4. PubMed ID: 8205403
[TBL] [Abstract][Full Text] [Related]
39. Microheterogeneity of acute phase proteins in the differentiation of polymyalgia rheumatica from polymyositis.
Pawlowski T; Aeschlimann A; Kahn MF; Vaith P; Mackiewicz SH; Mueller W
J Rheumatol; 1990 Sep; 17(9):1187-92. PubMed ID: 1705291
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica.
Narváez J; Estrada P; López-Vives L; Ricse M; Zacarías A; Heredia S; Gómez-Vaquero C; Nolla JM
Semin Arthritis Rheum; 2015 Dec; 45(3):328-33. PubMed ID: 26186807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
